Splash Pharmaceuticals logo — company profile

Splash Pharmaceuticals

Founded 2016 United States San Diego, United States 1 employees Series D Total: $22.99M Biotechnology, Pharmaceutical

General Information

Company Name Splash Pharmaceuticals
Founded Year 2016
Location United States San Diego, United States
Employees 1
Industries Biotechnology, Pharmaceutical
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Splash Pharmaceuticals. To contact Splash Pharmaceuticals, visit splashpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Splash Pharmaceuticals

Splash Pharmaceuticals is a privately held clinical stage oncology pharmaceutical company founded in 2001. It is focused on advancing innovative therapies against a novel and pivotal cancer target. The lead therapy has completed multiple Phase I and II clinical trials with promising results. The last significant investment was a Series D investment at 21 May 2018, with participation from Solstice Capital and Hamilton BioVentures. Based in the United States, Splash Pharmaceuticals operates in the biotechnology and pharmaceutical industries.

Taxonomy: Clinical Stage Pharmaceuticals, Oncology Therapies, Cancer Target Therapies, CD44 Targeted Agents, Anti-Angiogenic Therapies, Anti-Metastatic Therapies, Cytotoxicity, Pharmaceutical Development, Clinical Trials, Pharma Partnerships

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D Undisclosed 2
Solstice Capital, Hamilton BioVentures
21 May 2018
Series C Undisclosed -
22 Jul 2015
Series B $22.50M -
13 Nov 2008
Series A $491.00K -
07 Dec 2001

Splash Pharmaceuticals Alternatives & Competitors

View All Alternatives
Splash Pharmaceuticals vs
MimiVax, Inc.
MimiVax, Inc. United States

Disrupting Cancer with Immunotherapy

Venture round
3 employees
Biopharma, Biotechnology
Splash Pharmaceuticals vs
Inspirna, Inc.
Inspirna, Inc. United States

Converting cancer to a manageable, chronic condition

Series D
12 employees
Biotechnology, Health Care
Splash Pharmaceuticals vs

Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...

Series B
11 employees
Biotechnology, Health and Wellness

FAQ About Splash Pharmaceuticals

Splash Pharmaceuticals is a privately held clinical stage oncology pharmaceutical company advancing innovative therapies against a novel and pivotal cancer target. The lead therapy has completed multiple Phase I and II clinical trials with promising results.
Splash Pharmaceuticals was founded in 2016.
Splash Pharmaceuticals is headquartered in San Diego, United States.
Splash Pharmaceuticals operates in Biotechnology and Pharmaceutical. Its work centres on Clinical Stage Pharmaceuticals, Oncology Therapies, Cancer Target Therapies and CD44 Targeted Agents.
Splash Pharmaceuticals has approximately 1 employees.
Splash Pharmaceuticals has completed 4 funding rounds, raising a total of $22.99M. The latest funding stage is Series D.
Top alternatives and competitors to Splash Pharmaceuticals include MimiVax, Inc., Inspirna, Inc., Cybrexa Therapeutics, GLG Pharma, Prescient Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Splash Pharmaceuticals and MimiVax, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Splash Pharmaceuticals, https://bouncewatch.com/company/splash-pharmaceuticals, updated 19 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes